Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3441389 Title: COMPOSÉ PYRAZOLE-OXAZOLIDINONE POUR LUTTER CONTRE LE VIRUS DE L'HÉPATITE B

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
177786639
WO application number:
CN2017079552
Type:
European patent granted for BE
Status:
Open
Publication number:
3441389
WO publication number:
WO2017173999
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
06/04/2017
Grant date:
08/09/2021
EP publication date:
13/02/2019
WO publication date:
12/10/2017
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
08/09/2021
EP B1 publication date:
08/09/2021
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
06/04/2037

Applicant

Name:
Shanghai Zhimeng Biopharma, Inc.
Legal Form:
From:
08/09/2021
Address:
Room A302, A304, Building 1,1976 Gaoke Middle Road China (Shanghai) Pilot Free Trade Zone Pudong New Area, Shanghai 201210, China (CN)
To:

Agent

Name:
DENNEMEYER & ASSOCIATES
Legal Form:
From:
24/09/2021
Address:
Rue des Bruyères 55, 1274, Howald, Luxembourg (LU)
To:

Inventor

Name:
CHEN, Huanming
Legal Form:
Address:
Pudong, Shanghai 200135, China (CN)

Priority

Priority patent number:
201610210422
Priority date:
06/04/2016
Priority country:
China (CN)

Classification

IPC or IDT classification:
C07D 413/14; C07D 417/14; C07D 413/04; A61K 31/422; A61K 31/428; A61P 31/20;

Publication

Bulletin

Bulletin heading:
EP2
Journal edition number:
2021/17
Publication date:
06/10/2021
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

European Patent Bulletin

Issue number:
202136
Publication date:
08/09/2021
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
30/04/2026
Annual fee number:
10
Annual fee amount:
185 Euro
Expected payer:
Last annual fee payment date:
18/04/2025
Last annual fee paid number:
9
Last annual fee paid amount:
165 Euro
Payer:
DENNEMEYER & Co S.A.R.L.
Filing date Document type Publication Type Document Description Number of pages File Type
24/09/2021 Incoming Correspondence (Email) Cover letter 1 PDF /6/8/7/9/5/0722159786/docs/177786639_0_incomingcorrespondenceelectronic_20210925_084723455.pdf
24/09/2021 Outgoing Correspondence 1 PDF /6/8/7/9/5/0722159786/docs/177786639_1_outgoingcorrespondence_20210925_084721086.pdf
24/09/2021 General Document Declaration of domicile 1 PDF /6/8/7/9/5/0722159786/docs/177786639_2_generaldocument_20210925_084722651.pdf